CDK9-IN-12 - CAS 1942843-54-0

CDK9-IN-12 is a highly selective CDK9 inhibitor, which is commonly used in leukemia research to regulate oncogene expression, inhibit oncogenic proliferation, and induce apoptosis by targeting CDK9-dependent transcription processes.

CDK

Cell Cycle/Checkpoint

1942789

0.9893

C21H19ClN4O

378.86

ClC1=C(C=2C=C3C(=CC2)NN=C3C)C=C(N[C@@H](CO)C4=CC=CC=C4)C=N1

-20°C

Ice Packs

Small Compound